Abbott to Present at J.P. Morgan Healthcare ...( ABBOTT PARK Ill. A live audi...),Health
Navigation Links
Abbott to Present at J.P. Morgan Healthcare Conference
Date:12/16/2008
ABBOTT PARK, Ill., Dec. 16 /PRNewswire-FirstCall/ -- Abbott will present at the 27th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2009. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at noon Central time.
A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com. An archived edition of the presentation will be available later that day.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.
'/>"/>
| SOURCE Abbott Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. (Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
2. Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
3. Abbott Declares 340th Consecutive Quarterly Dividend
4. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
5. Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day
6. EGFR-targeting antibody licensed to Abbott
7. Abbott Honored as One of The Deals Most Admired Corporate Dealmakers
8. Abbott to Present at 17th Annual Credit Suisse Health Care Conference
9. Abbott Declares 339th Consecutive Quarterly Dividend
10. Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
11. Abbott Donates Diagnostic Instruments As Part of the Labs Are Vital(TM) Initiative
Post Your Comments:
(Date:11/22/2009)...teria are abundant, diverse and constant, but infl...ty of California, San Diego School of Medicine now... surface trigger a pathway that prevents excessive...ctually good for us," said Richard L. Gallo, MD, P... UCSD,s Division of Dermatology and the Dermatolog...
(Date:11/22/2009)...althSmart, an innovative healthcare benefit soluti...lly completed a recapitalization with Silver Point...rs. Silver Point Capital, L.P. is a private inves...recapitalization allows the Company to continue it..., (PRWEB) November 22, 200...
(Date:11/21/2009)... 21 Tonight, in a parti...tor Reid,s version of the government takeover of h...included in this bill; like the public option, emp...unding for elective abortion, which is the most on...bill provides subsidies for private plans that cov...
(Date:11/21/2009).... 21 A regional initiat...sis (river blindness) in the Americas has substant...ent years, as evidenced by a 31% decrease in the n...ation in six endemic countries. Results were repo...can Society of Tropical Medicine and Hygiene (ASTM...
(Date:11/21/2009)...novative medical apparel company launches men,s la... San Clemente, Calif. (PRWEB) November 2...dical apparel, today announced the launch of its m...9, a leading international trade fair for the medi... inaugurates its men,s collection with three varyi...
Breaking Medicine News(10 mins):Health News:Surface bacteria maintain skin's healthy balance 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3[0] Surface bacteria maintain skin's healthy balance[1] HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman [0] FRC: Senate Votes to Proceed with Abortion Funding Debacle[0] River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries[0] Medelita Introduces Men's Lab Coat Collection
... At a panel,discussion in Purcellville, VA on Marc...andidate for U.S. Congress in Virginia,s 10th Dist...sor Judy Feder, his opponent,in the June 10th Demo...eas for ending the war in Iraq, resolving the econ...
...he California,State Board of Pharmacy yesterday an...y authority to delay the implementation of E-Pedig...igree is the new track and trace,technology design...des with the recommendation that Dave Wilcox, RPh,...
...of Emergency Medicine is hosting the 11th annual S...um March 28-29 in Costa Mesa, Calif. As part of th...ll present research findings on a variety of relat...rgency department on-call coverage continues to wo...
...26 BD (Becton,Dickinson and Company) (NYSE: BDX ...ast of its second fiscal quarter 2008 earnings con... a.m. (ET). BD will issue a press release,detailin...stors and will be available for replay through,We...
...roundbreaking study conducted by University of Pit... the journal Brain (currently online) confirms tha...e beta-amyloid deposits found in the brains of pat... living patients. For a free-access link to the PD...
...t Data Research (TDR),President R.J. Slutz announc...nnual Step,N Forward fund raising campaign which w... "We are pleased to support Step,N Forward and the...ise the level of,care for our elders," said Target...
Other Medicine News:Health News:Democrat Mike Turner Backs Single-Payer Healthcare; Opponent Feder Undecided 2Health News:NCPA Statement on California's Delay of E-Pedigree Implementation 2Health News:UC Irvine researchers present latest findings at emergency medicine forum 2Health News:Study validates Pittsburgh Compound-B in identifying Alzheimer's disease brain toxins 2Health News:Study validates Pittsburgh Compound-B in identifying Alzheimer's disease brain toxins 3Democrat Mike Turner Backs Single-Payer Healthcare; Opponent Feder UndecidedNCPA Statement on California's Delay of E-Pedigree ImplementationUC Irvine researchers present latest findings at emergency medicine forumBD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallStudy validates Pittsburgh Compound-B in identifying Alzheimer's disease brain toxinsTarget Data Research Sponsors Forgotten Citizens Who Are in Need of Public Guardianship To Support and Manage Their Healthcare and Personal Needs
(Date:11/19/2009)... Alexza Pharmaceuticals, ...porate presentation will be webcast live during th... on Wednesday, December 2, 2009 at 9:00 a.m. Easte...e New York Palace Hotel in New York and will be pr...O. ,, To access the live presentation via the...
(Date:11/19/2009)...e/ -- As the seasons change, another season of cou...aring yourself. ,, Listen to this report from O..., http://inr.mediaseed.tv/oneClip_C/?feed=ksLp_f... division of The NewsMarket. Registered journalis...tos at http://www.thenewsmarket.com . ,, 10N...
(Date:11/19/2009)...ewswire/ -- Impliant, Inc., a developer of novel m...usion surgery, announced today that it has added N...Vice President of Clinical and Regulatory Affairs....prnh/20080527/NETU060LOGO ) ,, Mr. Rolon brin...in the spinal and medical device field to Impliant...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 48516 1NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 48516 2NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 48516 3NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 48516 4NUVIGIL Jet Lag Disorder Data Presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies 48516 5Neck Size May Affect Severity of Sleep Apnea 48511 1New family focused model of depression care needed to minimize risks 48506 1New family focused model of depression care needed to minimize risks 48506 2New family focused model of depression care needed to minimize risks 48506 3[0] Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference[0] AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season[0] Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team
..., England, January 12 Biotica Technology,Limited,... a significant,Collaboration and License Agreement...mercialise novel erythromycin-based macrolides in ...rch collaboration, Biotica will use its,bioenginee...readily,accessible via conventional medicinal chem...
... FRANCISCO, Jan. 9 Anesiva, Inc.,(Nasdaq: ANSV ...nistration,(FDA) has approved Anesiva,s supplement...ation for Zingo(TM) to treat the pain associated w...e hydrochloride monohydrate) powder,intradermal in...e pain,associated with peripheral IV insertions an...
Other Medicine Technology:Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline 2Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |